Program Overview

Program Overview

The MIT xPRO Drug and Medical Device Development: A Strategic Approach program is designed to provide a comprehensive understanding of the medical drug and product development process. This program aims to equip participants with a "big picture" perspective of the entire development process, from strategic planning to product commercialization.

Program Details

• Start Date: January 29, 2026
• Time Commitment: 5-6 hours/week
• Duration: 8 weeks, including orientation
• Format: Online
• CEUs: 4
• Price: $3,550

What You Will Learn

The program covers the following key areas:

• Gain a "big picture" perspective of the entire drug and medical device development process, from day one strategic planning through product commercialization
• Understand the critical interplay between strategy and development—and how they affect each other
• Learn frameworks for assessing both the benefits and the risks associated with developing a new product in the healthcare market
• Gain clarity around the regulatory requirements in the U.S. market and the process for achieving approval
• Develop professional networks for career development, industry partnerships, or strategic alliances

Who Should Enroll

The program is suitable for:

• Engineers involved in the development of new medical device products or pharmaceuticals
• Executives in the drug and medical device development/product management field
• Scientists and those who lead teams of scientists in R&D
• Quality assurance and regulatory affairs professionals
• Professionals making a horizontal transition into the healthcare industry
• Entrepreneurs seeking to launch a product in the U.S. healthcare market
  • Having a background in health sciences is helpful but not required.